Florence Gazeau, PhD in Physics (Université Paris Diderot, 1997) is a Senior Scientist (DRCE1) at CNRS. She is the director of NABI (Nanomedicine, Extracellular Biology, Integration, and Innovations for Health), a research lab launched in 2025 by Université Paris Cité, CNRS, and INSERM to advance translational research and innovation in nanomedicine and subcellular biotherapies.
NABI hosts IVETh (https://iveth.u-paris.fr), the first national integrator dedicated to bioproduction and biotherapy, focusing on the production, characterization, and engineering of extracellular vesicles and nanovectors for diagnostics and personalized therapies.
Florence Gazeau is also involved in the EVerZom spin-off, which specializes in the industrial-scale bioproduction of therapeutic extracellular vesicles using a proprietary turbulence-based technology, as well as Exosiris, a new spin-off devoted to engineered extracellular vesicles for in situ cell modification.
Recognized for her pioneering work in nanomagnetism and nanomedicine, she has authored about 220 publications. She was awarded the CNRS Silver Medal in 2024 and was elected to the French Academy of Sciences the same year.
